---
schema_version: "secwatch.filing_event.v1"
accession: "0001023024-24-000007"
form_type: "8-K"
ticker: "ANIP"
cik: "0001023024"
company_name: "ANI PHARMACEUTICALS INC"
filed_at: "2024-02-08T23:59:59+00:00"
generated_at: "2026-06-06T05:08:17.243511+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "medium"
source: SEC EDGAR
---

# ANI Pharmaceuticals to present at Guggenheim Healthcare Talks Biotechnology Conference

## Summary
- CEO Nikhil Lalwani and senior leadership to present at Guggenheim Healthcare Talks 6th Annual Biotechnology Conference on Feb 8, 2024.
- Investor presentation dated February 2024 attached as Exhibit 99.1.
- Disclosure made under Items 2.02 and 7.01 of Form 8-K.

## SEC filing metadata
- accession: 0001023024-24-000007
- form_type: 8-K
- ticker: ANIP
- cik: 0001023024
- company_name: ANI PHARMACEUTICALS INC
- filed_at: 2024-02-08T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: medium
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1023024/000102302424000007/0001023024-24-000007-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1023024/000102302424000007/ani-20240208.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001023024-24-000007
- JSON: https://secwatch.observer/filing/0001023024-24-000007.json
- Plain text: https://secwatch.observer/filing/0001023024-24-000007.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.